Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
Abstract Background Postmenopausal women compliance to alendronate therapy is suboptimal due to the complex dosing requirements. The poor compliance may increase their potential of fractures and the prevalence of side effects. In this study, the compliance of osteoporotic women on bisphosphonate the...
Saved in:
Main Authors: | Asma Radwan (Author), Naser Shraim (Author), Josephean Elaraj (Author), Anwar Hamad (Author), Dana Fatayer (Author), Bayan Jarar (Author), Ayoub Johar (Author), Areen Zriqah (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
by: Ruxu You, et al.
Published: (2020) -
Seven years’ experience with alendronate in postmenopausal Japanese women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2010) -
The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002) -
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004) -
Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005)